metronidazole has been researched along with vonoprazan in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 6 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Asaka, M; Funao, N; Murakami, K; Nishimura, A; Sakurai, Y; Shiino, M | 1 |
| Hasegawa, S; Nakamura, K; Nishimura, A; Okamoto, H; Sakurai, Y; Shiino, M | 1 |
| Kajihara, Y; Mizuki, I; Shimoyama, T | 1 |
| Arase, Y; Deguchi, R; Dekiden, M; Mine, T; Miyakita, H; Myojin, K; Ogimi, T; Shimada, H; Shiraishi, K | 1 |
| Eguchi, T; Fujita, M; Fukuchi, T; Hashimura, H; Kanamori, A; Kano, C; Koizumi, A; Matsumoto, K; Momose, K; Okada, A; Shimoyama, K; Tsujimae, M; Yamashita, H | 1 |
| Kato, M; Mabe, K; Nakagawa, S; Ono, S; Sakamoto, N | 1 |
| Hasuda, K; Hattori, M; Ido, Y; Okuda, A; Sakurai, K; Suda, H; Takeichi, T | 1 |
| Hu, Y; Lu, NH; Zhu, Y | 2 |
| Ando, K; Fujinaga, A; Fujiya, M; Goto, M; Ichiishi, E; Ito, T; Kashima, S; Kawamoto, T; Kohgo, Y; Moriichi, K; Nomura, Y; Okumura, T; Otake, T; Sato, K; Sato, T; Sugano, H; Tanabe, H; Ueno, N; Utsumi, T; Yanagawa, N | 1 |
| Fujibayashi, S; Fujiya, M; Goto, T; Kashima, S; Moriichi, K; Nomura, Y; Okumura, T; Sakatani, A; Sasajima, J; Tanaka, K; Ueno, N | 1 |
| Irie, K; Kaneko, H; Kondo, M; Maeda, S; Sasaki, T; Shibata, W; Sue, S | 1 |
| Fukuba, N; Ishitobi, H; Kinoshita, Y; Kobayashi, Y; Komazawa, Y; Kusunoki, M; Nagaoka, M; Shizuku, T; Takahashi, Y; Yuki, M | 1 |
| Ando, T; Handa, O; Horie, R; Imamoto, E; Itoh, Y; Murakami, T; Ose, T; Sendo, R; Suzuki, N | 1 |
| Graham, DY; Howden, CW | 1 |
| Adachi, K; Ebi, M; Funaki, Y; Izawa, S; Kasugai, K; Kato, S; Koshino, A; Nagao, K; Ogasawara, N; Ohashi, W; Sasaki, M; Sugiyama, T; Yamaguchi, Y; Yoshimine, T | 1 |
| Gotoda, T; Ishibashi, F; Suzuki, S | 1 |
3 review(s) available for metronidazole and vonoprazan
| Article | Year |
|---|---|
Novel and Effective Therapeutic Regimens for
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Mutation; Prevalence; Probiotics; Proton Pump Inhibitors; Pyrroles; Rifabutin; Sulfonamides; Tetracycline; Tetracycline Resistance | 2017 |
Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Remission Induction; Retrospective Studies; Sulfonamides; Time Factors; Treatment Outcome | 2017 |
Recent progress in Helicobacter pylori treatment.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Probiotics; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Vitamins | 2020 |
3 trial(s) available for metronidazole and vonoprazan
| Article | Year |
|---|---|
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2016 |
Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Healthy Volunteers; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2016 |
Randomized trial of vonoprazan-based versus proton-pump inhibitor-based third-line triple therapy with sitafloxacin for Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastritis; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sulfonamides; Treatment Failure; Treatment Outcome | 2019 |
12 other study(ies) available for metronidazole and vonoprazan
| Article | Year |
|---|---|
Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Retrospective Studies; Sulfonamides | 2017 |
Successful Eradication Therapy for Helicobacter pylori-positive Atrophic Gastritis at the Sixth Attempt: A Case Report.
Topics: Aged; Drug Therapy, Combination; Female; Fluoroquinolones; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Pyrroles; Sulfonamides; Treatment Failure; Treatment Outcome | 2016 |
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2016 |
Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin.
Topics: Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hypersensitivity; Male; Metronidazole; Middle Aged; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome; Urea | 2017 |
Comparative study: Vonoprazan and proton pump inhibitors in
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Patient Safety; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2017 |
Second-line therapy for Helicobacter pylori eradication causing antibiotic-associated hemorrhagic colitis.
Topics: Abdominal Pain; Aged; Amoxicillin; Biopsy; Colitis; Colon; Colonoscopy; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Hemorrhage; Humans; Klebsiella oxytoca; Metronidazole; Mucous Membrane; Pyrroles; Rare Diseases; Sulfonamides | 2017 |
Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for Helicobacter pylori Eradication.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Odds Ratio; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2019 |
Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2020 |
Recent Developments Pertaining to H. pylori Infection.
Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Pyrroles; Rifabutin; Stomach Neoplasms; Sulfonamides; Tetracycline; Treatment Outcome | 2021 |
Two vonoprazan combinations (Voquezna) for H. pylori.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2022 |
A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Hypersensitivity; Metronidazole; Penicillins; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2023 |
Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Proton Pump Inhibitors | 2023 |